Topoisomerase II inhibitors.

Cancer chemotherapy and biological response modifiers

Volumn 20, Issue , 2002, Pages 125-149

  Clapp, JaNae M ^a   Hande, Kenneth R ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME INHIBITOR;

ANIMAL; CLINICAL TRIAL; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; HUMANS; NEOPLASMS;

EID: 0037977806     PISSN: 09214410     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (253)